Explore

Trendline Trendline
Jasper Therapeutics and Kira Pharma Merge to Form Immunology-Focused Biotech

Jasper Therapeutics and Kira Pharma Merge to Form Immunology-Focused Biotech

Jasper Therapeutics and Kira Pharma Merge to Form Immunology-Focused Biotech
Trendline Trendline
Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Initiatives

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Initiatives

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Initiatives
Trendline Trendline
Jersey Mike's Plans $1 Billion IPO Amidst Challenging Market Conditions

Jersey Mike's Plans $1 Billion IPO Amidst Challenging Market Conditions

Jersey Mike's Plans $1 Billion IPO Amidst Challenging Market Conditions
Trendline Trendline
Agios Pharmaceuticals Discontinues Sickle Cell Drug Candidate After Failing to Outperform Competitors

Agios Pharmaceuticals Discontinues Sickle Cell Drug Candidate After Failing to Outperform Competitors

Agios Pharmaceuticals Discontinues Sickle Cell Drug Candidate After Failing to Outperform Competitors
Trendline Trendline
Engitix and Lonza Collaborate to Advance ADC Therapies

Engitix and Lonza Collaborate to Advance ADC Therapies

Engitix and Lonza Collaborate to Advance ADC Therapies
Trendline Trendline
AbelZeta's C-CAR168 Receives EMA PRIME Designation for Lupus Treatment

AbelZeta's C-CAR168 Receives EMA PRIME Designation for Lupus Treatment

AbelZeta's C-CAR168 Receives EMA PRIME Designation for Lupus Treatment
Trendline Trendline
Novartis Reports Growth Despite Entresto Sales Decline Due to Generic Competition

Novartis Reports Growth Despite Entresto Sales Decline Due to Generic Competition

Novartis Reports Growth Despite Entresto Sales Decline Due to Generic Competition
Trendline Trendline
Arcturus Therapeutics to Present at Canaccord Genuity Conference Highlighting mRNA Innovations

Arcturus Therapeutics to Present at Canaccord Genuity Conference Highlighting mRNA Innovations

Arcturus Therapeutics to Present at Canaccord Genuity Conference Highlighting mRNA Innovations
Trendline Trendline
Ashlins Pharmaceuticals Secures Exclusive License with Lee's Pharm for Interferon Alpha-2b Development

Ashlins Pharmaceuticals Secures Exclusive License with Lee's Pharm for Interferon Alpha-2b Development

Ashlins Pharmaceuticals Secures Exclusive License with Lee's Pharm for Interferon Alpha-2b Development
Trendline Trendline
FDA's 505(b)(2) Pathway: A Key Driver of Innovation Amid Regulatory Challenges

FDA's 505(b)(2) Pathway: A Key Driver of Innovation Amid Regulatory Challenges

FDA's 505(b)(2) Pathway: A Key Driver of Innovation Amid Regulatory Challenges
Trendline Trendline
Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Phase

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Phase

Altesa BioSciences Appoints Brett Haumann as CEO Amidst Strategic Growth Phase
Trendline Trendline
Samsung Biologics Announces Acquisition of PolyPeptide to Expand Global Network

Samsung Biologics Announces Acquisition of PolyPeptide to Expand Global Network

Samsung Biologics Announces Acquisition of PolyPeptide to Expand Global Network